Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Share Option Restructuring

9 Nov 2022 07:00

RNS Number : 7472F
Pennant International Group PLC
09 November 2022
 

 

FOR IMMEDIATE RELEASE 09 November 2022

PENNANT INTERNATIONAL GROUP PLC

 

Director/PDMR Shareholding

Share Option Restructuring

 

 

Pennant International Group plc (AIM: PEN) (the "Company"), announces the restructuring of the share options held by the executive directors, Philip Walker and David Clements.

 

Mr Walker has surrendered an EMI option over 297,619 unissued ordinary shares of 5p each in the capital of the Company ("ordinary shares") exercisable at 84p per share and an unapproved option over 525,969 unissued ordinary shares exercisable at 55p per share. Mr Clements has surrendered EMI options over 100,000 unissued ordinary shares exercisable at 80.5p and 205,455 unissued ordinary shares exercisable at 82.5p per share.

 

Following consultation with major shareholders, the Company has granted to Mr Walker a new EMI option over 500,000 unissued ordinary shares, and Mr Clements has been granted a new EMI option over 300,000 unissued ordinary shares (the "New Options"). The New Options are the only options (or other rights to acquire shares in the Company) held by the executive directors.

The New Options are subject to vesting conditions tied to achieving growth in the Company's share price, vesting in 20% tranches as and when certain milestones are achieved and the share price sustained at that level for at least 30 days, as follows:

 

Target share price

 

% of New Options vesting

 

 

57p

20%

62p

20%

67p

20%

72p

20%

77p

20%

 

In order for the New Options to vest, these targets must be achieved during the three years following the date of grant (the "Performance Period") and to the extent that the New Options have not vested during the Performance Period, the rights over the unissued shares will lapse. Any shares that are acquired pursuant to exercise of the New Options must be held by the relevant executive director for at least the Performance Period. The exercise price under the New Options is 33.5p per share.

 

The New Options are subject to further conditions contained in the Company's EMI scheme document, as approved by shareholder vote in 2019. Each executive director's New Options lapse should his employment cease.

The tables below provide further details for each PDMR.

 

 

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director 

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

 https://www.whirelandplc.com/capital-markets

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Philip Walker

2

 

Reason for the notification

 

a)

 

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Pennant International Group plc

b)

 

LEI

2138005AIIUYSRP5O254

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

GB0002570660

b)

 

Nature of the transaction

Option award 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Award of shares

£0.335

500,000

d)

 

Aggregated information

Award of shares

- Aggregated volume

500,000

- Price

£167,500

e)

 

Date of the transaction

 

8 November 2022

f)

 

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

David Clements

2

 

Reason for the notification

 

a)

 

Position/status

Commercial & Risk Director

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Pennant International Group plc

b)

 

LEI

2138005AIIUYSRP5O254

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

GB0002570660

b)

 

Nature of the transaction

Option award 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Award of shares

£0.335

300,000

d)

 

Aggregated information

Award of shares

- Aggregated volume

300,000

- Price

£100,500

e)

 

Date of the transaction

 

8 November 2022

f)

 

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVTLILTIIF
Date   Source Headline
11th Sep 20207:00 amRNSHolding(s) in Company
8th Sep 20207:00 amRNSHoldings in Company
13th Aug 20207:00 amRNSTrading Update & Notice of Interim Results
29th Jul 20203:47 pmRNSDirector/PDMR Shareholding
17th Jul 20207:00 amRNSNew Contract & Notice of Half-Year Trading Update
22nd May 20207:00 amRNSBusiness Update
15th May 202012:00 pmRNSResult of AGM
20th Apr 20201:58 pmRNSIssue of Equity and Director Dealing
20th Apr 20207:00 amRNS2019 Preliminary Results
25th Mar 20207:00 amRNSCovid-19 Update
16th Mar 202012:51 pmRNSNotice of Results
10th Mar 202012:00 pmRNSContract Update
3rd Mar 202010:00 amRNSCompletion of Australian Acquisition
19th Feb 20207:00 amRNSStatement of Intent for Prospective £5m Contract
7th Feb 202011:08 amRNSHolding(s) in Company
3rd Feb 20207:00 amRNSContract Wins
3rd Feb 20207:00 amRNSTrading Update
22nd Jan 20204:58 pmRNSHoldings in Company
21st Jan 20207:00 amRNS£3.44m Australian Acquisition
22nd Nov 20197:00 amRNSBoard Re-organisation & Directorate Changes
7th Nov 20198:15 amRNSHoldings in Company
31st Oct 201910:48 amRNSNew £3.4m Contract Award and Qatar Update
24th Sep 20197:00 amRNS2019 Interim Results
9th Sep 20197:00 amRNSLaunch of Aviation Skills Charter
15th Aug 201910:07 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirector/PDMR Shareholding
9th Aug 20197:00 amRNSPre-Close Trading Update
31st Jul 20196:11 pmRNSHolding(s) in Company
19th Jul 20197:00 amRNSAcquisition of Track Access
18th Jun 20197:00 amRNSHolding(s) in Company
14th Jun 20197:31 amRNSAppointment of Non-Executive Director
2nd May 20191:30 pmRNSDirector Dealings
2nd May 20197:00 amRNSMajor Programme Update
1st May 20193:30 pmRNSResult of AGM
9th Apr 20197:00 amRNSIssue of Equity and Director Dealings
19th Mar 20195:02 pmRNSHolding(s) in Company
12th Mar 20195:21 pmRNSPublication of 2018 Annual Report
12th Mar 20197:00 amRNS2018 Final Results
8th Feb 20194:17 pmRNSDirector Dealing
7th Feb 20197:35 amRNSAcquisition Completed
4th Feb 201910:22 amRNSHolding(s) in Company
4th Feb 201910:19 amRNSHolding(s) in Company
29th Jan 201912:45 pmRNSResult of Placing
29th Jan 20197:00 amRNSProposed Placing
21st Jan 20197:00 amRNSTrading Update
18th Dec 20184:48 pmRNSHolding(s) in Company
12th Nov 20183:36 pmRNSHolding in Company
8th Nov 201810:31 amRNSMajor New Contract Award & Contracts Update
16th Oct 201810:15 amRNSHoldings in Company
15th Oct 20185:32 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.